Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasms × disitamab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Urinary Bladder Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 HER2-positive Gastric Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Exercise 6 Standard of Care 5 Radiotherapy 4 trametinib 3 Radiosurgery 3 Palliative Care 3 Paclitaxel 3 Carboplatin 3 trastuzumab deruxtecan 2 tislelizumab 2 Surveys and Questionnaires 2 Oxaliplatin 2 Music Therapy 2 Meditation 2 Maintenance 2 Magnetic Resonance Spectroscopy 2 Focus Groups 2 Drug Therapy 2 Data Collection 2 Biopsy 2 Anastrozole 2 130-nm albumin-bound paclitaxel 2 vedolizumab 1 toripalimab 1 surufatinib 1 sparsentan 1 sintilimab 1 semaglutide 1 sargramostim 1 posaconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07142200 2025-08-26

DECIDING

RenJi Hospital

Phase 2 Not yet recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡